Biologics reshape the future of lupus care

Daniel Scherman

Rare Disease and Orphan Drugs Journal ›› 2025, Vol. 4 ›› Issue (4) : 30

PDF
Rare Disease and Orphan Drugs Journal ›› 2025, Vol. 4 ›› Issue (4) :30 DOI: 10.20517/rdodj.2025.59
Editorial

Biologics reshape the future of lupus care

Author information +
History +
PDF

Cite this article

Download citation ▾
Daniel Scherman. Biologics reshape the future of lupus care. Rare Disease and Orphan Drugs Journal, 2025, 4(4): 30 DOI:10.20517/rdodj.2025.59

登录浏览全文

4963

注册一个新账户 忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within
[1]

Furie RA,Kalunian K.LILAC Trial InvestigatorsTrial of anti-BDCA2 antibody Litifilimab for systemic lupus erythematosus.N Engl J Med2022;387:894-904

[2]

Werth VP,Romero-Diaz J.LILAC Trial InvestigatorsTrial of anti-BDCA2 antibody Litifilimab for cutaneous lupus erythematosus.N Engl J Med2022;387:321-31

[3]

Furie R.Management strategies using biologics in systemic lupus erythematosus.Rare Dis Orphan Drugs J2025;4:22

AI Summary AI Mindmap
PDF

315

Accesses

0

Citation

Detail
Sections
Recommended

AI思维导图

/

〈 〉